Source:http://linkedlifedata.com/resource/pubmed/id/17015410
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
13
|
pubmed:dateCreated |
2006-11-1
|
pubmed:abstractText |
Platelet components have found successful clinical utilization to initiate or to accelerate tissue-repair mechanisms. However, the molecular pathways by which platelet factors contribute to tissue regeneration have not been fully elucidated. We have studied the effect of thrombin-activated platelets (TAPs) on cell growth in vivo and in cultured cell systems. Application of TAPs to ulcerative skin lesions of diabetic patients induced local activation of ERK1/2 and Akt/PKB. Moreover, when applied to cultured human skin fibroblasts, TAPs promoted cell growth and DNA synthesis and activated platelet-derived growth factor (PDGF) and insulin-like growth factor (IGF)-1 receptor tyrosine kinases. PDGF was released by TAPs and rapidly achieved a plateau. At variance, the release of IGF-1 was mainly provided by the TAPs-stimulated fibroblasts and progressively increased up to 48 h. The PDGF-R blocker Ag1296 reduced the activation of Akt/PKB and, at a lesser extent, of ERK1/2. Conversely, inhibition of IGF-1 signaling by Ag1024 and expression of a dominant-negative IGF-1R mutant selectively reduced the stimulation of ERK1/2 by TAPs and fibroblast-released factors, with minor changes of Akt/PKB activity. Thus, platelet factors promote fibroblast growth by acutely activating Akt/PKB and ERK1/2. Sustained activation of ERK1/2, however, requires autocrine production of IGF-1 by TAPs-stimulated fibroblasts.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1530-6860
|
pubmed:author |
pubmed-author:BeguinotFrancescoF,
pubmed-author:D'AgostinoElioE,
pubmed-author:FioryFrancescaF,
pubmed-author:FormisanoPietroP,
pubmed-author:FormisanoSalvatoreS,
pubmed-author:FratellanzaGiorgioG,
pubmed-author:GiaccoFerdinandoF,
pubmed-author:MieleClaudiaC,
pubmed-author:MissoSaverioS,
pubmed-author:OrienteFrancescoF,
pubmed-author:PernaEnzoE,
pubmed-author:PerruoloGiuseppeG,
pubmed-author:SaldalamacchiaGennaroG
|
pubmed:issnType |
Electronic
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2402-4
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:17015410-Blood Platelets,
pubmed-meshheading:17015410-Cell Culture Techniques,
pubmed-meshheading:17015410-Cell Division,
pubmed-meshheading:17015410-Fibroblasts,
pubmed-meshheading:17015410-Humans,
pubmed-meshheading:17015410-Insulin-Like Growth Factor I,
pubmed-meshheading:17015410-Platelet Activation,
pubmed-meshheading:17015410-Proto-Oncogene Proteins c-akt,
pubmed-meshheading:17015410-Skin,
pubmed-meshheading:17015410-Skin Physiological Phenomena,
pubmed-meshheading:17015410-Thrombin
|
pubmed:year |
2006
|
pubmed:articleTitle |
Thrombin-activated platelets induce proliferation of human skin fibroblasts by stimulating autocrine production of insulin-like growth factor-1.
|
pubmed:affiliation |
Dipartimento di Biologia e Patologia Cellulare e Molecolare, Università di Napoli Federico II, Via Pansini 5, 80131 Napoli, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|